Cannabinoid Hyperemesis Syndrome

Authors

  • Kriengsak Jaikla School of Medicine, Mae Fah Luang University, Chiang Rai 57100, Thailand
  • Kaset Chimplee School of Medicine, Mae Fah Luang University, Chiang Rai 57100, Thailand

Keywords:

Cannabinoid hyperemesis syndrome, Cyclic vomiting syndrome, Tetrahydrocannabinol

Abstract

Cannabinoid Hyperemesis Syndrome (CHS) is a condition characterized by cyclic episodes of nausea and vomiting, abdominal pain, and relief of symptoms by taking of hot shower, this syndrome being associated with chronic cannabis use. CHS occurs in approximately one-third of individuals presenting with cannabis use disorder. The pathophysiology of CHS is not fully understood, but it is believed to involve the endocannabinoid system (ECS). This report describes an 18-year-old female, with a history of marijuana consumption spanning nearly two years, who presented with intense nausea and vomiting. The patient made a complete recovery following cannabis abstinence and supportive treatment. Two months follow-up revealed a full resolution of the symptoms.

References

Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015; 313: 2456. https://doi.org/10.1001/jama.2015.6358

Perisetti A. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Ann Gastroenterol [Internet]. 2020 [cited 2023 Sep 21]; available from: http:// www.annalsgastro.gr/files/journals/ 1/earlyview/2020/ev-09-2020-01-AG_ 5230-0528.pdf

DeVuono MV, Parker LA. Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms. Cannabis Cannabinoid Res. 2020; 5: 132-44. https://doi.org/10.1089/can.2019.0059

Gajendran M, Sifuentes J, Bashashati M, McCallum R. Cannabinoid Hyperemesis Syndrome: Definition, Pathophysiology, Clinical Spectrum, Insights into Acute and Long-Term Management. J Investig Med. 2020; 68: 1309-16. https://doi.org/10.1136/jim-2020-001564

Leu N, Routsolias JC. Cannabinoid Hyperemesis Syndrome: A Review of the Presentation and Treatment. J Emerg Nurs. 2021; 47: 483-6. https://doi.org/10.1016/j.jen.2020.11.006

Stumpf JL, Williams LD. Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin. J Pharm Pract. 2021; 34: 786-93. https://doi.org/10.1177/0897190020934289

Galli JA, Sawaya RA, Friedenberg FK. Cannabinoid Hyperemesis Syndrome. Curr Drug Abuse Rev. 2011; 4: 241-9. https://doi.org/10.2174/1874473711104040241

Venkatesan T, Levinthal DJ, Li BUK, Tarbell SE, Adams KA, Issenman RM, et al. Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome. Neurogastroenterol Motil. 2019; 31(S2): e13606. https://doi.org/10.1111/nmo.13606

Drossman DA, Hasler WL. Rome IV- Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016; 150: 1257-61. https://doi.org/10.1053/j.gastro.2016.03.035

Stanghellini V, Chan FKL, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. Gastroduodenal Disorders. Gastroenterology. 2016; 150: 1380-92. https://doi.org/10.1053/j.gastro.2016.02.011

Richards JR. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department. J Emerg Med. 2018; 54: 354-63. https://doi.org/10.1016/j.jemermed.2017.12.010

Pergolizzi Jr. JV, LeQuang JA, Bisney JF. Cannabinoid Hyperemesis. Med Cannabis Cannabinoids. 2018; 1: 73-95. https://doi.org/10.1159/000494992

Senderovich H, Patel P, Lopez BJ, Waicus S. A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options. Med Princ Pract. 2022; 31: 29-38. https://doi.org/10.1159/000520417

Bajgoric S, Samra K, Chandrapalan S, Gautam N. Cannabinoid hyperemesis syndrome: a guide for the practising clinician. BMJ Case Rep. 2015; bcr2015210246. https://doi.org/10.1136/bcr-2015-210246

Beech RA, Sterrett DR, Babiuk J, Fung H. Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review. J Oral Maxillofac Surg. 2015; 73: 1907-10. https://doi.org/10.1016/j.joms.2015.03.059

Nogueira JM, Fonseca I, Duarte M. Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition. GE - Port J Gastroenterol. 2021; 28: 420-4. https://doi.org/10.1159/000512088

Wagner S, Hoppe J, Zuckerman M, Schwarz K, McLaughlin J. Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department. Clin Toxicol. 2020; 58: 471-5. https://doi.org/10.1080/15563650.2019.1660783

Downloads

Published

2024-01-08

How to Cite

Jaikla, K., & Chimplee, K. (2024). Cannabinoid Hyperemesis Syndrome. Greater Mekong Subregion Medical Journal, 4(1), 37–41. Retrieved from https://he02.tci-thaijo.org/index.php/gmsmj/article/view/265874

Issue

Vol. 4 No. 1 (2024): January - April

Section

Case Report

License

Copyright (c) 2024 Greater Mekong Subregion Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.